| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.048 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |